Doctor Cristina Chimenti
Sapienza University of Rome, Rome (Italy)
Long-term clinical-pathologic results of enzyme replacement therapy in pre-hypertrophic fabry disease cardiomyopathy.
Event: ESC Congress 2024
Topic: Pathophysiology and Mechanisms
Session: New insights into pharmacotherapy for acute heart failure
Treatment of virus negative chronic myocarditis: Long term follow-up of TIMIC trial
Event: ESC Congress 2020
Topic: Myocarditis
Session: Myocardial Disease ePosters
Hypertrophy of unaffected cardiomyocytes concurs to severity of cardiomyopathy in female patients with Fabry disease
Event: ESC Congress 2018
Topic: Infiltrative Myocardial Disease
Session: Cardiomyopathy in Fabry disease
Telomere shortening in human hypertrophic cardiomyopathy
Event: Heart Failure 2018
Topic: Hypertrophic Cardiomyopathy
Session: Myocardial Disease – Clinical
Immune-mediated myocarditis in fabry disease cardiomyopathy
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Myocarditis
Session: Cardiomyopathy
Myocardial regeneration in human hypertrophic cardiomyopathy
Event: ESC Congress 2016
Topic: Cardiomyopathies
Session: Cardiomyopathy
Myocardial expression of Toll-like receptor 4 predicts the response to immunosuppressive therapy in patients with virus negative inflammatory cardiomyopathy
Event: ESC Congress 2016
Topic: Myocarditis
Session: Best Posters in myocarditis
